Why is Torrent Pharma falling/rising?

As of 05-Sep, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at Rs 3,581.00, which reflects a decrease of Rs 11.6 or 0.32%. The stock has underperformed its sector by 0.25% today and has seen a consecutive fall over the last two days, resulting in a total decline of 0.53%. Despite reaching an intraday high of Rs 3,750, the stock's performance has been hindered by lower trading volumes, with delivery volume decreasing by 16.93% compared to the five-day average. While the stock has shown positive returns year-to-date at 6.72% and over the past three years at 135.64%, it has struggled in the short term, with a slight decline of 0.23% over the past month.
In the broader market context, the Sensex has increased by 1.13% over the past week, indicating that Torrent Pharmaceuticals is lagging behind the benchmark. The company benefits from high management efficiency, a strong ability to service debt, and consistent positive results over the last eight quarters, which contribute to its overall stability. However, the recent drop in investor participation and the stock's underperformance relative to the sector may be influencing its current price movement. Despite these challenges, the stock's long-term performance remains strong, outperforming the BSE500 in the last three annual periods, which suggests that while short-term fluctuations are present, the fundamentals of the company remain solid.